retatrutide what is it clinical trial A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide Dosing Schedule: Proven 2026

Pernicious Anemia According to research, Pernicious Anemia is one of the most common reasons for Vitamin B12 deficiency

Lipotropic injections may be considered by adults who want nutrient support as part of a broader wellness routine

We look forward to offering guidance on these emerging brain benefits of GLP-1 medications

received a project support grant from the British Society for Neuroendocrinology

For some patients, weight regain despite intensive lifestyle efforts may warrant consideration of resuming tirzepatide or transitioning to alternative anti-obesity medications, provided they meet FDA-indicated criteria (BMI 30 kg/m or 27 kg/m with weight-related comorbidity)